Article Information
History
- April 6, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Yosuke Hirotsu1,*,
- Makoto Maejima2,
- Masahiro Shibusawa2,
- Yume Natori2,
- Yuki Nagakubo2,3,
- Kazuhiro Hosaka2,
- Hitomi Sueki2,
- Hitoshi Mochizuki1,4,5,
- Toshiharu Tsutsui6,
- Yumiko Kakizaki6,
- Yoshihiro Miyashita6 and
- Masao Omata5,7
- 1Genome Analysis Center, Yamanashi Central Hospital, 1-1-1 Fujimi, Kofu, Yamanashi, Japan
- 2Division of Microbiology in Clinical Laboratory, Yamanashi Central Hospital, 1-1-1 Fujimi, Kofu, Yamanashi, Japan
- 3Division of Genetics and Clinical Laboratory, Yamanashi Central Hospital, 1-1-1 Fujimi, Kofu, Yamanashi, Japan
- 4Central Clinical Laboratory, Yamanashi Central Hospital, 1-1-1 Fujimi, Kofu, Yamanashi, Japan
- 5Department of Gastroenterology, Yamanashi Central Hospital, 1-1-1 Fujimi, Kofu, Yamanashi, Japan
- 6Lung Cancer and Respiratory Disease Center, Yamanashi Central Hospital, 1-1-1 Fujimi, Kofu, Yamanashi, Japan
- 7The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
- ↵*Corresponding author: Yosuke Hirotsu, Genome Analysis Center, Yamanashi Central Hospital, 1-1-1 Fujimi, Kofu, Yamanashi, Japan, Email: hirotsu-bdyu{at}ych.pref.yamanashi.jp, Tel: +81-55-253-7111, Fax: +81-55-253-8011
Posted April 06, 2022.
SARS-CoV-2 Omicron sublineage BA.2 replaces BA.1.1: genomic surveillance in Japan from September 2021 to March 2022
